Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ESAB CorpESAB · Entity 3958 | Director · President and CEO | June 10, 2026 | June 12, 2026 |
| Enovis CORPCFX · Entity 4797 | ESAB President and EVP, Colfax | March 07, 2022 | March 09, 2022 |
| Veralto CorpVLTO · Entity 3203 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ESAB Corp
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $82.92 · Expires 2033-06-09 | Direct | 580,552 |
Reported balance
After 2026-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 580,552 · Balance 580,552 F1: The performance stock option to purchase up to 580,552 shares of ESAB common stock vests in three tranches based on ESAB's satisfaction of certain performance criteria during the four-year period commencing on the second anniversary of the grant date and ending on the sixth anniversary of the grant date, subject to the reporting person's continued service through the later of each of the fourth, fifth and sixth anniversaries of the grant date and the date on which ESAB's achievement of the applicable performance criteria has been certified. |
Filing footnotes · ownership attribution and instrument terms
F1: The performance stock option to purchase up to 580,552 shares of ESAB common stock vests in three tranches based on ESAB's satisfaction of certain performance criteria during the four-year period commencing on the second anniversary of the grant date and ending on the sixth anniversary of the grant date, subject to the reporting person's continued service through the later of each of the fourth, fifth and sixth anniversaries of the grant date and the date on which ESAB's achievement of the applicable performance criteria has been certified.
Enovis CORP
Report date March 07, 2022 · Filed March 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $.001SEC Table I · non-derivative | Direct | 100,985 |
Reported balance
After 2022-03-07 transaction · row 1
1 source rowRow 1 · 2022-03-07 · Sale · Disposed 2,788 · Balance 100,985 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.
Veralto Corp
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,470 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 1,099 · Balance 3,470 F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.00 · Expires 2036-07-15 | Direct | 9,413 |
Reported balance
After 2026-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-15 · Grant · Acquired 3,553 · Balance 9,413 F2: The options granted to our non-employee directors will be fully vested as of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
F2: The options granted to our non-employee directors will be fully vested as of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2021 Filed Feb 25, 2021 01:36 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 23,105 | $0.00 Strike: $44.91 | $0.00 |
DisclosureSEC source: 0001209191-21-014060 · doc4.xml · derivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,105 Underlying: Common stock, par value $.001 · 23,105 shares Expires 2028-02-21 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:36 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 9,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-014060 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,239 F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 2,357 | $37.41 | $88,175.37 |
DisclosureSEC source: 0001209191-20-063631 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,855 F1 · kind: These shares were sold to meet tax obligations relating to the vesting of restricted stock units granted to the reporting person on December 13, 2019. F1 · shares: These shares were sold to meet tax obligations relating to the vesting of restricted stock units granted to the reporting person on December 13, 2019. Read SEC document |
| May 14, 2020 Filed May 15, 2020 15:41 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 14,829 | $22.97 | $340,622.13 |
DisclosureSEC source: 0001209191-20-029590 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,212 F1 · kind: These shares were sold to meet tax obligations relating to the vesting and delivery of restricted stock units and performance-based restricted stock units granted upon his hire date of May 13, 2016. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 22:45 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 31,017 | $0.00 Strike: $37.67 | $0.00 |
DisclosureSEC source: 0001209191-20-013157 · doc4.xml · derivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,017 Underlying: Common stock, par value $.001 · 31,017 shares Expires 2027-02-23 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 22:45 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 10,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013157 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,041 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 21:19 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 14,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-060863 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,860 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:03 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 4,100 | $36.06 | $147,862.40 |
DisclosureSEC source: 0001209191-19-055526 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,163 Read SEC document |
| May 14, 2019 Filed May 16, 2019 23:52 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 11,764 | $26.27 | $309,016.75 |
DisclosureSEC source: 0001209191-19-030645 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,263 F1 · kind: These shares were sold to meet tax obligations relating to the vesting and delivery of restricted stock units and performance-based restricted stock units granted upon his hire date of May 13, 2016. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 22:27 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 74,032 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001209191-19-014157 · doc4.xml · derivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,032 Underlying: Common Stock, par value $.001 · 74,032 shares Expires 2026-02-24 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:24 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon Stock, par value $.001 | 15,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045677 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,027 F1 · kind: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. F1 · shares: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:28 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 873 | $32.48 | $28,350.68 |
DisclosureSEC source: 0001209191-18-030232 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,271 F1 · kind: These shares were sold to meet tax obligations relating to the vesting and delivery of restricted stock units granted upon his hire. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:54 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 58,027 | $0.00 Strike: $33.41 | $0.00 |
DisclosureSEC source: 0001209191-18-018884 · doc4.xml · derivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,027 Underlying: Common Stock, par value $.001 · 58,027 shares Expires 2025-03-07 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:19 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 42,123 | $0.00 Strike: $40.47 | $0.00 |
DisclosureSEC source: 0001209191-17-011055 · doc4.xml · derivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and SVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,123 Underlying: Common Stock, par value $.001 · 42,123 shares Expires 2024-02-12 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.